Skip to main content
  • Academy Gains New Intel to Enhance Our Federal Advocacy on Drug Prices


    At Mid-Year Forum 2018, we convened impressive experts for a timely discussion of the next salvo in the fight to stop rising costs for pharmaceutical treatments